PNPLA3基因在糖尿病中与肝脏脂质含量和胰岛素抵抗的作用
该研究在德国糖尿病研究(GDS)的917名新发糖尿病患者中,探讨PNPLA3 rs738409(G)多态性与肝脏脂质含量及胰岛素敏感性的关联。结果显示G等位基因与肝细胞脂质含量正相关(β=0.36,P<0.01),且严重胰岛素抵抗糖尿病(SIRD)亚组携带该变异更常见,其脂肪组织胰岛素抵抗和游离脂肪酸升高可能促进NAFLD。
要点
- PNPLA3 rs738409(G)与肝细胞脂质含量独立正相关(β=0.36,P<0.01)。
- SIRD亚组rs738409(G)携带率高于其他亚组和糖耐量正常组(P<0.05)。
- G等位基因携带者脂肪组织胰岛素抵抗和游离脂肪酸更高(P<0.001)。
核心结论
- SIRD亚组更常携带PNPLA3 rs738409(G)变异,该变异相关脂肪组织胰岛素抵抗和过度脂解可能促进NAFLD。
研究设计与样本
- 德国糖尿病研究(GDS)纳入917名参与者,进行基因分型、高胰岛素-正葡萄糖钳夹联合稳定同位素示踪稀释和MRS。
主要发现
- G等位基因与肝细胞脂质含量正相关(β=0.36,P<0.01),独立于年龄、性别和BMI,但在各亚组内不显著。
- SIRD组全身体胰岛素敏感性低于SIDD、MOD、MARD和SAID组(均P<0.001)。
- SIRD组rs738409(G)患病率高于其他亚组和糖耐量正常组(P<0.05)。
- SIRD组肝细胞脂质含量中位数13.6%(第1四分位5.8;第3四分位19.1),高于MOD组6.4%(2.1;12.4,P<0.05)、MARD组3.0%(1.0;7.9,P<0.001)、SAID组0.4%(0.0;1.5,P<0.001)和糖耐量正常组0.9%(0.4;4.9,P<0.001)。
- 在SIRD中PNPLA3多态性未直接与全身体胰岛素敏感性相关,但G等位基因携带者游离脂肪酸更高且脂肪组织胰岛素抵抗更重(均P<0.001)。
临床怎么用
- 对SIRD亚群患者应考虑PNPLA3 rs738409基因型检测以评估NAFLD风险。
- 针对脂肪组织胰岛素抵抗和脂解可能为SIRD相关NAFLD的干预方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The rs738409(G) single nucleotide polymorphism (SNP) in the patatin-like phospholipase domain-containing 3 (PNPLA3) gene associates with increased risk and progression of nonalcoholic fatty liver disease (NAFLD). As the recently described severe insulin-resistant diabetes (SIRD) cluster specifically relates to NAFLD, this study examined whether this SNP differently associates with hepatic lipid content (hepatocellular lipids [HCL]) and insulin sensitivity in recent-onset diabetes. RESEARCH DESIGN AND METHODS: A total of 917 participants in the German Diabetes Study (GDS) underwent genotyping, hyperinsulinemic-euglycemic clamps with stable isotopic tracer dilution, and MRS. RESULTS: The G allele associated positively with HCL (β = 0.36, P < 0.01), independent of age, sex, and BMI across the whole cohort, but not in the individual clusters. Those with SIRD exhibited lowest whole-body insulin sensitivity compared with those with severe insulin-deficient (SIDD), moderate obesity-related (MOD), moderate age-related (MARD), and severe autoimmune diabetes (SAID) clusters (all P < 0.001). Interestingly, the SIRD group presented with higher prevalence of the rs738409(G) SNP compared with other clusters and the glucose-tolerant control group (P < 0.05). HCL was higher in the SIRD group (median 13.6% [1st quartile 5.8; 3rd quartile 19.1] compared with the MOD (6.4 % [2.1; 12.4], P < 0.05), MARD (3.0% [1.0; 7.9], P < 0.001), SAID (0.4% [0.0; 1.5], P < 0.001), and glucose-tolerant (0.9% [0.4; 4.9), P < 0.001) group. Although the PNPLA3 polymorphism did not directly associate with whole-body insulin sensitivity in SIRD, the G-allele carriers had higher circulating free fatty acid concentrations and greater adipose tissue insulin resistance compared with noncarriers (both P < 0.001). CONCLUSIONS: Members of the SIRD cluster are more frequently carriers of the rs738409(G) variant. The SNP-associated adipose tissue insulin resistance and excessive lipolysis may contribute to their NAFLD.
引用
- Zaharia OP, Strassburger K, Knebel B, et al. Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes. Diabetes Care. 2020. PMID: 32910776. doi:10.2337/dc20-0329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。